Ridgetech RDGT

NASDAQ RDGT
$1.13 +0.13 (+13.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Ridgetech (RDGT) stock price is $1.13, up 13.00% on the day, as of Nov 9, 2026. It has a market cap of $6.37Mn, and is classified in the Drug Distribution industry (Healthcare sector).

Key Stats
Market Cap6.37 Mn
P/E-3.28
FCF (Yr)-1.39 Mn
ROA (Yr)-1.87
EV to EBIT31.24
Net Income (Yr)-1.25 Mn
Enterprise Value-56.25 Mn
Add ratio to table…

About

Ridgetech, Inc. is a holding company incorporated in the Cayman Islands that conducts substantially all of its business operations in China. Following the disposition of its retail pharmacy business, the company focuses on the wholesale distribution of pharmaceutical products through both offline and online channels. The company generates revenue by selling third party pharmaceutical products including prescription drugs over the counter drugs nutritional supplements…

Read more ↓
Sector: Healthcare Sector rationale Ridgetech operates as a wholesale distributor of pharmaceutical products, including prescription drugs, over-the-counter drugs, and medical devices, selling to clinics and pharmacies. This activity falls directly under the 'Drug Distribution' industry within the Healthcare sector. Industry: Drug Distribution Drug Distribution Primary Ridgetech focuses on the wholesale distribution of third-party pharmaceutical products, including prescription drugs and medical devices, through its subsidiaries Jiuxin Medicine and Allright. Its revenue is derived from selling these products to drug distributors, retail pharmacies, clinics, and third-party trading companies. Classified using BQ-MICS CIK: 0001856084

Product and Service Breakdown of Revenue (2026)

History

Segments Breakdown of Revenue (2026)

History
Peer percentiles

How Ridgetech ranks

Ranked against the 27 companies in Healthcare Payers and Distributors58 metrics · as of Nov 6, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −3.28xMedian 25.1x 20th
  • P/FCFNegative free cash flow −3.11xMedian 16.4x 4th
  • P/Operating cash flow —Median 13.6x No data —
  • P/S 0.03xMedian 0.40x 96th
  • P/B 0.11xMedian 2.64x 99th
  • P/Tangible book 0.11xMedian 3.26x 99th
  • EV/EBITDA —Median 14.2x No data —
  • EV/EBIT —Median 18.9x No data —
  • EV/Revenue —Median 0.44x No data —
  • EV/FCF —Median 17.8x No data —
  • EV/Operating cash flow —Median 15.3x No data —
  • PEG (3Y EPS CAGR) —Median 1.51 No data —
Peer group

Peer Comparison

Companies in the Drug Distribution
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 UNH Unitedhealth Group Inc 356.05 Bn22.420.7974.33 Bn
2 MCK Mckesson Corp 123.13 Bn26.200.299.21 Bn
3 CVS CVS HEALTH Corp 109.04 Bn9.880.2660.68 Bn
4 ELV Elevance Health, Inc. 90.56 Bn17.620.4530.76 Bn
5 CI Cigna Group 77.41 Bn12.920.2731.14 Bn
6 COR Cencora, Inc. 66.63 Bn25.390.2011.72 Bn
7 CAH Cardinal Health Inc 63.51 Bn34.930.258.82 Bn
8 RDGT Ridgetech Inc. 0.01 Bn-3.280.030.00 Bn